Important Information on the Legal Fight Against Medicare Drug Price Negotiations
The court battle surrounding Medicare’s drug price negotiation program is intensifying as the deadline for determining which drugs will be included approaches. Currently, there are five organizations, including three pharmaceutical companies and two trade groups, that are suing the federal government over the Medicare Drug Price Negotiation Program. This program is an essential component of …